Floatz logo

Therapeutic Asset Ratings

409 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[225Ac]-FPI-1966
Ovarian Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
a2b543
Ovarian Cancer
A2 Biotherapeutics Inc.P1/2CC (40)
a2b694
Ovarian Cancer
A2 Biotherapeutics Inc.P1/2CC (40)
Ace-86225106
Ovarian Cancer
Acerand Therapeutics (Shanghai) LimitedP1/2CC (40)
Alnodesertib
Ovarian Cancer
Artios Pharma LtdP1/2CC (40)
AMXI-5001
Ovarian Cancer
AtlasMedx, IncorporatedP1/2CC (40)
Anti-Hcd70 Car Transduced Pbl
Ovarian Cancer
National Cancer Institute (NCI)P1/2CC (40)
Anti-Mesothelin Chimeric T Cell Receptor Transduced Peripheral Blood Lymphocytes
Ovarian Cancer
Weijia Fang, MDP1/2CC (40)
Apl-5125
Ovarian Cancer
Apollo Therapeutics LtdP1/2CC (40)
asp0739
Ovarian Cancer
Astellas Pharma Global Development, Inc.P1/2CC (40)
azd5305
Ovarian Cancer
AstraZenecaP1/2CC (40)
bi-1808
Ovarian Cancer
BioInvent International ABP1/2CC (40)
Camizestrant
Ovarian Cancer
AstraZenecaP1/2CC (40)
dc05f01
Ovarian Cancer
Heronova PharmaceuticalsP1/2CC (40)
Deoxycholic Acid
Ovarian Cancer
THERAPIM PTY LTDP1/2CC (40)
dnTGFβRII
Ovarian Cancer
University of ChicagoP1/2CC (40)
Dual-Target Antigen-Selected Car-Nk
Ovarian Cancer
Essen BiotechP1/2CC (40)
EBNK-001
Ovarian Cancer
Essen BiotechP1/2CC (40)
Eb-Select Single-Target Car-Nk Cells
Ovarian Cancer
Essen BiotechP1/2CC (40)
Etx-19477
Ovarian Cancer
858 Therapeutics, Inc.P1/2CC (40)
fhb7h3.car-ts
Ovarian Cancer
The Affiliated Hospital of Xuzhou Medical UniversityP1/2CC (40)
Gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV4-31*01 (89.9%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo sapiens IGHG1*01 (100%), G1m17,1 CH1 K120, D12, L14 (CH1 K120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-214')-disulfide with kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-12*01 (85.3%)-IGKJ2*01 (100%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, derived from the cell line CHO-K1,glycoform alfa
Ovarian Cancer
Cancer Research UKP1/2CC (40)
Gavo-Cel
Ovarian Cancer
TCR2 TherapeuticsP1/2CC (40)
gen1107
Ovarian Cancer
GenmabP1/2CC (40)
gpc3 cd146 car-t cells
Ovarian Cancer
Essen BiotechP1/2CC (40)
Showing 201 to 225 of 409 assets
PreviousPage 9 of 17Next